A.C.E.| Seminar 1：Building a strong patent portfolio to gain market competitive advantages

Starting from 2023, Medicilon will host a series of webinars with a wide range of critical topics in biotech industry, including IP strategies, licensing, M&A, investment, due diligence, finance, company management, the business environment between United States and China, as well as how Medicilon can support with its 20 years of establishment and new research and technology platforms.

During the webinars, Medicilon will invite a group of senior industrial experts and executives in related fields to systematically introduce the ideas and key elements, share their experience, and conduct the in-depth discussions. We sincerely invite you to join us!

Agenda

About Medicilon

Medicilon is an integrated contract research organization (CRO), providing comprehensive one-step new drug R&D services for pharmaceutical enterprises and scientific research institutions around the world.

Based on key links of drug R&D, we focus on the demand for innovation and the development of the global pharmaceutical industry. With our experience in serving domestic and foreign biomedical industries, we have built an integrated technical platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, in a bid to provide comprehensive preclinical new drug R&D for the global biomedical industry. For enquiries, please email marketing@medicilon.com.

Scan to register